PB

Paul Berns

Managing Director at ARCH Venture Partners

Wisconsin

Overview 

Paul Berns is the Managing Director at ARCH Venture Partners, focusing on investing in Series B stage companies primarily in the pharmaceuticals and biotech sectors in the San Francisco Bay Area. Notable investments include Metsera (Series A) and BlackThorn Therapeutics (Series B).

Investments 

Metsera

Series A

Total funding: $290M

Matter Neuroscience

Seed

Total funding: $26M

Areteia Therapeutics

Series A

Total funding: $430M

HI-Bio

Series A

Total funding: $220M

Articles About Paul

Relevant Websites